Novocure™ is pleased to introduce the second generation Optune System. It is smaller and lighter, weighing just 2.7 lbs.
The second generation Optune System offers features that enhance carrying comfort and usability:
Easy-grip texture allows for better handling
Battery indicator displays power and alerts you when it’s time to change the battery
Light-detecting sensor auto-dims the device and the charger in the dark
Portable batteries: 4 batteries are provided with each kit; each battery lasts for 2 to 3 hours
Charger for portable batteries: Batteries will need to be recharged for 2 to 4 hours. The batteries can be charged and used many times for about 6 to 9 months
Plug-in power supply and power cords: New “No-Stop Swap” enables you to swap batteries or power source without disrupting delivery of TTFields
1. Optune Patient Information and Operation Manual. Novocure 2016.
Locate a nearby treatment center where doctors are certified to prescribe Optune.Find a certified center
Learn how nCompass supports Optune users every step of the way.Discover nCompass
Optune is a wearable, portable, FDA-approved device indicated to treat a type of brain cancer called glioblastoma multiforme (GBM) in adult patients 22 years of age or older.
If you have newly diagnosed GBM, Optune is used together with a chemotherapy called temozolomide (TMZ) if:
If your tumor has come back, Optune can be used alone as an alternative to standard medical therapy if:
Optune is not for everyone. Talk to your doctor if you have:
Do not use Optune if you are pregnant or are planning to become pregnant. It is not known if Optune is safe or effective during pregnancy.
Optune should only be used after receiving training from qualified personnel, such as your doctor, a nurse, or other medical staff who have completed a training course given by Novocure™, the maker of Optune.
Most common side effects of Optune when used together with chemotherapy (temozolomide, or TMZ) were low blood platelet count, nausea, constipation, vomiting, tiredness, scalp irritation from the device, headache, seizure, and depression.
The most common side effects when using Optune alone were scalp irritation (redness and itchiness) and headache. Other side effects were malaise, muscle twitching, fall and skin ulcers.
Talk to your doctor if you have any of these side effects or questions.
Please click here to see the Optune Instructions For Use (IFU) for complete information regarding the device's indications, contraindications, warnings, and precautions.
Optune is intended as a treatment for adult patients (22 years of age or older) with histologically-confirmed glioblastoma multiforme (GBM).